Congenital adrenal hyperplasia (CAH) is a common metabolic genetic disease. Early diagnosis and intervention are crucial to improve the prognosis. Noninvasive prenatal diagnosis (NIPD) is an early, safe, and accurate… Click to show full abstract
Congenital adrenal hyperplasia (CAH) is a common metabolic genetic disease. Early diagnosis and intervention are crucial to improve the prognosis. Noninvasive prenatal diagnosis (NIPD) is an early, safe, and accurate method. This study aimed to evaluate the NIPD of CAH while guiding individualized intrauterine treatment.
Keywords:
adrenal hyperplasia;
congenital adrenal;
intrauterine treatment;
individualized intrauterine
Journal Title: Prenatal Diagnosis
Year Published: 2025
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Prenatal Diagnosis
Year Published: 2025
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!